Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.
Identifieur interne : 001353 ( PubMed/Corpus ); précédent : 001352; suivant : 001354Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.
Auteurs : Jiandong Shi ; Jing Zhang ; Sijin Li ; Jing Sun ; Yumei Teng ; Meini Wu ; Jianfan Li ; Yanhan Li ; Ningzhu Hu ; Haixuan Wang ; Yunzhang HuSource :
- PloS one [ 1932-6203 ] ; 2015.
English descriptors
- KwdEn :
- Antibodies, Neutralizing (immunology), Coronavirus Infections (immunology), Coronavirus Infections (virology), Epitopes, B-Lymphocyte (immunology), Epitopes, T-Lymphocyte (immunology), Humans, Immunity, Cellular (immunology), Middle East Respiratory Syndrome Coronavirus (immunology), Nucleocapsid Proteins (immunology), Spike Glycoprotein, Coronavirus (immunology), T-Lymphocytes, Helper-Inducer (immunology), Viral Vaccines (immunology).
- MESH :
- chemical , immunology : Antibodies, Neutralizing, Epitopes, B-Lymphocyte, Epitopes, T-Lymphocyte, Nucleocapsid Proteins, Spike Glycoprotein, Coronavirus, Viral Vaccines.
- immunology : Coronavirus Infections, Immunity, Cellular, Middle East Respiratory Syndrome Coronavirus, T-Lymphocytes, Helper-Inducer.
- virology : Coronavirus Infections.
- Humans.
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) with pandemic potential is a major worldwide threat to public health. However, vaccine development for this pathogen lags behind as immunity associated with protection is currently largely unknown. In this study, an immunoinformatics-driven genome-wide screening strategy of vaccine targets was performed to thoroughly screen the vital and effective dominant immunogens against MERS-CoV. Conservancy and population coverage analysis of the epitopes were done by the Immune Epitope Database. The results showed that the nucleocapsid (N) protein of MERS-CoV might be a better protective immunogen with high conservancy and potential eliciting both neutralizing antibodies and T-cell responses compared with spike (S) protein. Further, the B-cell, helper T-cell and cytotoxic T lymphocyte (CTL) epitopes were screened and mapped to the N protein. A total of 15 linear and 10 conformal B-cell epitopes that may induce protective neutralizing antibodies were obtained. Additionally, a total of 71 peptides with 9-mer core sequence were identified as helper T-cell epitopes, and 34 peptides were identified as CTL epitopes. Based on the maximum HLA binding alleles, top 10 helper T-cell epitopes and CTL epitopes that may elicit protective cellular immune responses against MERS-CoV were selected as MERS vaccine candidates. Population coverage analysis showed that the putative helper T-cell epitopes and CTL epitopes could cover the vast majority of the population in 15 geographic regions considered where vaccine would be employed. The B- and T-cell stimulation potentials of the screened epitopes is to be further validated for their efficient use as vaccines against MERS-CoV. Collectively, this study provides novel vaccine target candidates and may prompt further development of vaccines against MERS-CoV and other emerging infectious diseases.
DOI: 10.1371/journal.pone.0144475
PubMed: 26641892
Links to Exploration step
pubmed:26641892Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.</title>
<author><name sortKey="Shi, Jiandong" sort="Shi, Jiandong" uniqKey="Shi J" first="Jiandong" last="Shi">Jiandong Shi</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zhang, Jing" sort="Zhang, Jing" uniqKey="Zhang J" first="Jing" last="Zhang">Jing Zhang</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Sijin" sort="Li, Sijin" uniqKey="Li S" first="Sijin" last="Li">Sijin Li</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sun, Jing" sort="Sun, Jing" uniqKey="Sun J" first="Jing" last="Sun">Jing Sun</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Teng, Yumei" sort="Teng, Yumei" uniqKey="Teng Y" first="Yumei" last="Teng">Yumei Teng</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wu, Meini" sort="Wu, Meini" uniqKey="Wu M" first="Meini" last="Wu">Meini Wu</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Jianfan" sort="Li, Jianfan" uniqKey="Li J" first="Jianfan" last="Li">Jianfan Li</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Yanhan" sort="Li, Yanhan" uniqKey="Li Y" first="Yanhan" last="Li">Yanhan Li</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hu, Ningzhu" sort="Hu, Ningzhu" uniqKey="Hu N" first="Ningzhu" last="Hu">Ningzhu Hu</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Haixuan" sort="Wang, Haixuan" uniqKey="Wang H" first="Haixuan" last="Wang">Haixuan Wang</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hu, Yunzhang" sort="Hu, Yunzhang" uniqKey="Hu Y" first="Yunzhang" last="Hu">Yunzhang Hu</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26641892</idno>
<idno type="pmid">26641892</idno>
<idno type="doi">10.1371/journal.pone.0144475</idno>
<idno type="wicri:Area/PubMed/Corpus">001353</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001353</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.</title>
<author><name sortKey="Shi, Jiandong" sort="Shi, Jiandong" uniqKey="Shi J" first="Jiandong" last="Shi">Jiandong Shi</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zhang, Jing" sort="Zhang, Jing" uniqKey="Zhang J" first="Jing" last="Zhang">Jing Zhang</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Sijin" sort="Li, Sijin" uniqKey="Li S" first="Sijin" last="Li">Sijin Li</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sun, Jing" sort="Sun, Jing" uniqKey="Sun J" first="Jing" last="Sun">Jing Sun</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Teng, Yumei" sort="Teng, Yumei" uniqKey="Teng Y" first="Yumei" last="Teng">Yumei Teng</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wu, Meini" sort="Wu, Meini" uniqKey="Wu M" first="Meini" last="Wu">Meini Wu</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Jianfan" sort="Li, Jianfan" uniqKey="Li J" first="Jianfan" last="Li">Jianfan Li</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Yanhan" sort="Li, Yanhan" uniqKey="Li Y" first="Yanhan" last="Li">Yanhan Li</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hu, Ningzhu" sort="Hu, Ningzhu" uniqKey="Hu N" first="Ningzhu" last="Hu">Ningzhu Hu</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Haixuan" sort="Wang, Haixuan" uniqKey="Wang H" first="Haixuan" last="Wang">Haixuan Wang</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hu, Yunzhang" sort="Hu, Yunzhang" uniqKey="Hu Y" first="Yunzhang" last="Hu">Yunzhang Hu</name>
<affiliation><nlm:affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">PloS one</title>
<idno type="eISSN">1932-6203</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Neutralizing (immunology)</term>
<term>Coronavirus Infections (immunology)</term>
<term>Coronavirus Infections (virology)</term>
<term>Epitopes, B-Lymphocyte (immunology)</term>
<term>Epitopes, T-Lymphocyte (immunology)</term>
<term>Humans</term>
<term>Immunity, Cellular (immunology)</term>
<term>Middle East Respiratory Syndrome Coronavirus (immunology)</term>
<term>Nucleocapsid Proteins (immunology)</term>
<term>Spike Glycoprotein, Coronavirus (immunology)</term>
<term>T-Lymphocytes, Helper-Inducer (immunology)</term>
<term>Viral Vaccines (immunology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Neutralizing</term>
<term>Epitopes, B-Lymphocyte</term>
<term>Epitopes, T-Lymphocyte</term>
<term>Nucleocapsid Proteins</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Immunity, Cellular</term>
<term>Middle East Respiratory Syndrome Coronavirus</term>
<term>T-Lymphocytes, Helper-Inducer</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Middle East respiratory syndrome coronavirus (MERS-CoV) with pandemic potential is a major worldwide threat to public health. However, vaccine development for this pathogen lags behind as immunity associated with protection is currently largely unknown. In this study, an immunoinformatics-driven genome-wide screening strategy of vaccine targets was performed to thoroughly screen the vital and effective dominant immunogens against MERS-CoV. Conservancy and population coverage analysis of the epitopes were done by the Immune Epitope Database. The results showed that the nucleocapsid (N) protein of MERS-CoV might be a better protective immunogen with high conservancy and potential eliciting both neutralizing antibodies and T-cell responses compared with spike (S) protein. Further, the B-cell, helper T-cell and cytotoxic T lymphocyte (CTL) epitopes were screened and mapped to the N protein. A total of 15 linear and 10 conformal B-cell epitopes that may induce protective neutralizing antibodies were obtained. Additionally, a total of 71 peptides with 9-mer core sequence were identified as helper T-cell epitopes, and 34 peptides were identified as CTL epitopes. Based on the maximum HLA binding alleles, top 10 helper T-cell epitopes and CTL epitopes that may elicit protective cellular immune responses against MERS-CoV were selected as MERS vaccine candidates. Population coverage analysis showed that the putative helper T-cell epitopes and CTL epitopes could cover the vast majority of the population in 15 geographic regions considered where vaccine would be employed. The B- and T-cell stimulation potentials of the screened epitopes is to be further validated for their efficient use as vaccines against MERS-CoV. Collectively, this study provides novel vaccine target candidates and may prompt further development of vaccines against MERS-CoV and other emerging infectious diseases. </div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26641892</PMID>
<DateCompleted><Year>2016</Year>
<Month>06</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>10</Volume>
<Issue>12</Issue>
<PubDate><Year>2015</Year>
</PubDate>
</JournalIssue>
<Title>PloS one</Title>
<ISOAbbreviation>PLoS ONE</ISOAbbreviation>
</Journal>
<ArticleTitle>Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.</ArticleTitle>
<Pagination><MedlinePgn>e0144475</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0144475</ELocationID>
<Abstract><AbstractText>Middle East respiratory syndrome coronavirus (MERS-CoV) with pandemic potential is a major worldwide threat to public health. However, vaccine development for this pathogen lags behind as immunity associated with protection is currently largely unknown. In this study, an immunoinformatics-driven genome-wide screening strategy of vaccine targets was performed to thoroughly screen the vital and effective dominant immunogens against MERS-CoV. Conservancy and population coverage analysis of the epitopes were done by the Immune Epitope Database. The results showed that the nucleocapsid (N) protein of MERS-CoV might be a better protective immunogen with high conservancy and potential eliciting both neutralizing antibodies and T-cell responses compared with spike (S) protein. Further, the B-cell, helper T-cell and cytotoxic T lymphocyte (CTL) epitopes were screened and mapped to the N protein. A total of 15 linear and 10 conformal B-cell epitopes that may induce protective neutralizing antibodies were obtained. Additionally, a total of 71 peptides with 9-mer core sequence were identified as helper T-cell epitopes, and 34 peptides were identified as CTL epitopes. Based on the maximum HLA binding alleles, top 10 helper T-cell epitopes and CTL epitopes that may elicit protective cellular immune responses against MERS-CoV were selected as MERS vaccine candidates. Population coverage analysis showed that the putative helper T-cell epitopes and CTL epitopes could cover the vast majority of the population in 15 geographic regions considered where vaccine would be employed. The B- and T-cell stimulation potentials of the screened epitopes is to be further validated for their efficient use as vaccines against MERS-CoV. Collectively, this study provides novel vaccine target candidates and may prompt further development of vaccines against MERS-CoV and other emerging infectious diseases. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shi</LastName>
<ForeName>Jiandong</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Yunnan Provincial Key Laboratory of Arbo Infectious Disease Control Research (Preparing), Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>Jing</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Prenatal Diagnosis Center, Shijiazhuang Obstetrics and Gynecology Hospital, Shijiazhuang, Hebei, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Sijin</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Yunnan Provincial Key Laboratory of Arbo Infectious Disease Control Research (Preparing), Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sun</LastName>
<ForeName>Jing</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Yunnan Provincial Key Laboratory of Arbo Infectious Disease Control Research (Preparing), Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Teng</LastName>
<ForeName>Yumei</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Yunnan Provincial Key Laboratory of Arbo Infectious Disease Control Research (Preparing), Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wu</LastName>
<ForeName>Meini</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Yunnan Provincial Key Laboratory of Arbo Infectious Disease Control Research (Preparing), Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Jianfan</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Yunnan Provincial Key Laboratory of Arbo Infectious Disease Control Research (Preparing), Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Yanhan</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Yunnan Provincial Key Laboratory of Arbo Infectious Disease Control Research (Preparing), Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hu</LastName>
<ForeName>Ningzhu</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Yunnan Provincial Key Laboratory of Arbo Infectious Disease Control Research (Preparing), Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Haixuan</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Yunnan Provincial Key Laboratory of Arbo Infectious Disease Control Research (Preparing), Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hu</LastName>
<ForeName>Yunzhang</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Yunnan Provincial Key Laboratory of Arbo Infectious Disease Control Research (Preparing), Institute of Medical Biology, Chinese Academy of Medical Sciences, Kunming, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2015</Year>
<Month>12</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS One</MedlineTA>
<NlmUniqueID>101285081</NlmUniqueID>
<ISSNLinking>1932-6203</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018985">Epitopes, B-Lymphocyte</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018984">Epitopes, T-Lymphocyte</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019590">Nucleocapsid Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018985" MajorTopicYN="N">Epitopes, B-Lymphocyte</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018984" MajorTopicYN="N">Epitopes, T-Lymphocyte</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007111" MajorTopicYN="N">Immunity, Cellular</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D065207" MajorTopicYN="N">Middle East Respiratory Syndrome Coronavirus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019590" MajorTopicYN="N">Nucleocapsid Proteins</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006377" MajorTopicYN="N">T-Lymphocytes, Helper-Inducer</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>10</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2015</Year>
<Month>11</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2015</Year>
<Month>12</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2015</Year>
<Month>12</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>6</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26641892</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pone.0144475</ArticleId>
<ArticleId IdType="pii">PONE-D-15-41720</ArticleId>
<ArticleId IdType="pmc">PMC4671582</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>BMC Bioinformatics. 2007;8:361</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17897458</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Drug Discov. 2007 May;6(5):404-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17473845</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W509-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18463140</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1985 Sep;55(3):836-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2991600</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Nov;87(21):11950-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23986586</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2006 Mar 30;347(1):127-39</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16387339</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Sep;87(17):9939-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23824801</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Commun. 2015;6:7712</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26218507</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2009;4(6):e5861</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19516900</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2013 Aug;23(8):986-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23835475</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2003 Jan 17;21(5-6):419-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12531640</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2013 Jan;171(1):54-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23123213</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Res. 2015 Apr 16;202:60-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25656066</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2007;2(8):e796</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17726526</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2012;17(40):20290</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23078800</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Bioinformatics. 2007;8:4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17207271</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Bioinformatics. 2006;7:153</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16545123</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2013;8(12):e81587</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24324708</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Biochem Sci. 2000 Mar;25(3):147-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10694887</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2006 Apr 12;24(16):3100-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16494977</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2013 Oct;19(10):1697-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24050621</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunogenetics. 2009 Jan;61(1):1-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19002680</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods Mol Biol. 1999;112:531-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10027275</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Structure. 1994 Apr 15;2(4):245-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8087551</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunome Res. 2008 Jan 25;4:2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18221540</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biotechnol Lett. 2009 Nov;31(11):1685-93</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19579009</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2013;4(5):e00650-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24023385</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2001 Mar;75(6):2660-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11222689</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Appl Microbiol Biotechnol. 2012 Mar;93(6):2437-46</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22134641</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Vaccine Immunol. 2010 Jun;17(6):1027-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20410327</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Hum Vaccin Immunother. 2015;11(5):1244-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25874632</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2006 May 15;24(20):4343-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16581161</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2006 Aug 15;177(4):2138-45</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16887973</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2007 Jun;81(11):6079-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17392374</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Expert Rev Vaccines. 2014 Jun;13(6):761-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24766432</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2015 Aug;89(16):8651-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26018172</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Comput Biol. 2013 Oct;9(10):e1003266</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24204222</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2014 May;88(10):5209-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24600003</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Struct Biol. 1999 Dec;9(6):745-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10607669</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FEBS Lett. 1990 Dec 10;276(1-2):172-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1702393</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2015 Sep 5;386(9997):995-1007</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26049252</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunogenetics. 2013 Oct;65(10):711-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23900783</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2015 Nov;71(5):599-602</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26165609</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brief Bioinform. 2012 May;13(3):350-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21949215</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nucleic Acids Res. 2012 Jul;40(Web Server issue):W525-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22610854</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proteins. 1994 Jun;19(2):141-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8090708</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Lett. 2008 Jun 15;118(1):65-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18440652</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virol J. 2010;7:351</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21118546</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2014 Oct 14;32(45):5975-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25192975</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>FEBS J. 2007 Aug;274(16):4211-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17645546</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Mol Immunol. 2006 Dec;3(6):459-65</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17257500</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2009 Aug 6;27(36):5001-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19523911</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Rep. 2015;5:12501</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26238798</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2013 Aug;87(16):9379-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23785207</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MBio. 2014;5(3):e01146-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24781747</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Methods Mol Biol. 2014;1137:17-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24573471</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunology. 2015 Aug;145(4):476-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25762305</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Protein Sci. 2003 May;12(5):1007-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12717023</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMC Bioinformatics. 2005;6:132</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15927070</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Expert Rev Vaccines. 2015 Jan;14(1):21-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25193104</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001353 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001353 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:26641892 |texte= Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26641892" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |